Back to Search
Start Over
Increased resistance to fibrinolysis activation in patients with coronavirus disease 2019: a case series.
- Source :
-
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis [Blood Coagul Fibrinolysis] 2021 Jun 01; Vol. 32 (4), pp. 298-301. - Publication Year :
- 2021
-
Abstract
- We describe seven critically ill and seven noncritically ill patients with coronavirus disease 2019 infection. Two viscoelastic assays were performed with ClotPro technology, activated by extrinsic system test and recombinant tissue plasminogen activator challenge test. Coagulation profile presents a marked hypercoagulability with increased resistance to fibrinolysis, reflected by tissue plasminogen activator test. Our pathological observations show that the hypercoagulative status described in these patients is, at least partially, secondary to fibrinolysis shutdown.<br /> (Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.)
- Subjects :
- Adult
Aged
Blood Cell Count
Blood Coagulation Tests
COVID-19 complications
Comorbidity
Critical Illness
Disease Progression
Female
Hemorrhage epidemiology
Hemorrhage etiology
Hospital Mortality
Hospitals, Urban
Humans
Intensive Care Units
Male
Middle Aged
Patients' Rooms
Recombinant Proteins
Spain epidemiology
Thromboembolism epidemiology
Thromboembolism etiology
Thrombophilia blood
Tissue Plasminogen Activator
COVID-19 blood
Fibrinolysis
SARS-CoV-2
Thrombophilia etiology
Subjects
Details
- Language :
- English
- ISSN :
- 1473-5733
- Volume :
- 32
- Issue :
- 4
- Database :
- MEDLINE
- Journal :
- Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis
- Publication Type :
- Academic Journal
- Accession number :
- 33491994
- Full Text :
- https://doi.org/10.1097/MBC.0000000000001017